German Market Access – Simplified
Everything you need to know in one place, explained in simple terms
Introduction The Institute for Quality and Efficiency in Health Care (IQWiG), in its pursuit of promoting evidence-based healthcare decisions, continuously refines its
Here are the G-BA decisions from the G-BA meeting held on 19 October 2023 on the early benefit assessments of Hemgenix, Libtayo,
Here are the G-BA decisions from the G-BA meeting held on 5 October 2023 on the early benefit assessments of Imfinzi, Imjudo,
Here are the G-BA decisions from the G-BA meeting held on 21 September 2023 on the early benefit assessments of Nubeqa, Spravato,
Here are the G-BA decisions from the G-BA meeting held on 17 August 2023 on the early benefit assessments of Carvykti, Hemlibra,